Literature DB >> 34520818

KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.

Yingqiang Lu1, Haixiang Qin2, Bo Jiang2, Wenfeng Lu2, Jiange Hao2, Wenmin Cao2, Lin Du3, Wei Chen2, Xiaozhi Zhao2, Hongqian Guo4.   

Abstract

The metastatic dissemination and underlying mechanisms of clear cell renal cell carcinoma (ccRCC) remain insufficiently understood. In this study, we identified the essential role of KLF2 in suppressing the metastasis of ccRCC. Downregulation of KLF2 detected by immunohistochemistry in primary metastatic ccRCC was remarkably related to poor clinical outcomes. Overexpression of KLF2 in vitro inhibited growth, migration and invasion of RCC cells. Analysis of clinical specimens revealed that there is a close correlation between KLF2 and GPX4 in ccRCC. Mechanistically, KLF2 deficiency is sufficient to inhibit ferroptosis on account of the impairment of transcriptional repression of GPX4 and thus promotes the migration and invasion of RCC cells. Reverting KLF2 expression in vivo decreased pulmonary metastatic lesions and prolonged life span of mice, whereas GPX4 overexpression reversed these properties. Overall, our results established a novel critical pathway that drives human ccRCC invasion and metastasis, which could be a promising target regarding to the therapies of advanced ccRCC in the clinic.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Clear cell renal cell carcinoma; Ferroptosis; KLF2; Metastasis

Mesh:

Substances:

Year:  2021        PMID: 34520818     DOI: 10.1016/j.canlet.2021.09.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression.

Authors:  Junpeng Ji; Huibing Li; Wenjun Wang; Bo Yuan; Tianyu Shen
Journal:  Hum Cell       Date:  2022-07-23       Impact factor: 4.374

2.  MicroRNA-4735-3p Facilitates Ferroptosis in Clear Cell Renal Cell Carcinoma by Targeting SLC40A1.

Authors:  Cairong Zhu; Zhiquan Song; Zhen Chen; Tianqi Lin; Haili Lin; Zhenqiang Xu; Fen Ai; Shijiao Zheng
Journal:  Anal Cell Pathol (Amst)       Date:  2022-05-19       Impact factor: 4.133

3.  HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation.

Authors:  Shangting Han; Fangyou Lin; Yucheng Qi; Cong Liu; Linxiang Zhou; Yuqi Xia; Kang Chen; Ji Xing; Zilin Liu; Weimin Yu; Yunlong Zhang; Xiangjun Zhou; Ting Rao; Fan Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-04-25       Impact factor: 7.310

4.  The functions and prognostic value of Krüppel-like factors in breast cancer.

Authors:  Ke-Yun Zhu; Yao Tian; Ying-Xi Li; Qing-Xiang Meng; Jie Ge; Xu-Chen Cao; Ti Zhang; Yue Yu
Journal:  Cancer Cell Int       Date:  2022-01-15       Impact factor: 5.722

Review 5.  Ferroptosis in Cancer Progression: Role of Noncoding RNAs.

Authors:  Ying-Bing Zuo; Yin-Feng Zhang; Rui Zhang; Jia-Wei Tian; Xiao-Bing Lv; Rong Li; Shu-Ping Li; Meng-Die Cheng; Jing Shan; Zheng Zhao; Hui Xin
Journal:  Int J Biol Sci       Date:  2022-02-14       Impact factor: 6.580

6.  Shikonin Could Be Used to Treat Tubal Pregnancy via Enhancing Ferroptosis Sensitivity.

Authors:  Gaopi Deng; Jie Gao; Yuling Lai; Fuling Zeng; Zhenyue Chen; Min Feng; Yanxi Huang; Pin Qiu; Lihua Zeng; Yan Ke
Journal:  Drug Des Devel Ther       Date:  2022-07-01       Impact factor: 4.319

7.  GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.

Authors:  Sitian Wei; Zhicheng Yu; Rui Shi; Lanfen An; Qi Zhang; Qian Zhang; Tangansu Zhang; Jun Zhang; Hongbo Wang
Journal:  BMC Cancer       Date:  2022-08-12       Impact factor: 4.638

8.  ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.

Authors:  Elena Arconada-Luque; Jaime Jiménez-Suarez; Raquel Pascual-Serra; Syong Hyun Nam-Cha; Teresa Moline; Francisco J Cimas; Germán Fliquete; Marta Ortega-Muelas; Olga Roche; Diego M Fernández-Aroca; Raúl Muñoz Velasco; Natalia García-Flores; Cristina Garnés-García; Adrián Sánchez-Fdez; Sofía Matilla-Almazán; Víctor J Sánchez-Arévalo Lobo; Javier Hernández-Losa; Borja Belandia; Atanasio Pandiella; Azucena Esparís-Ogando; Santiago Ramón Y Cajal; Luis Del Peso; Ricardo Sánchez-Prieto; María José Ruiz-Hidalgo
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

9.  Bioinformatics analysis of KLF2 as a potential prognostic factor in ccRCC and association with epithelial-mesenchymal transition.

Authors:  Fangfang Hu; Yan Ren; Zunyun Wang; Hui Zhou; Yumei Luo; Minghua Wang; Faqing Tian; Jian Zheng; Juan Du; Gang Pang
Journal:  Exp Ther Med       Date:  2022-07-05       Impact factor: 2.751

10.  Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases.

Authors:  Zhijun Han; Hao Wang; Jing Long; Yanning Qiu; Xiao-Liang Xing
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.